Endo Inc.

In News

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS - Business Wire

Business Wire - May 18, 2026

Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader - PR Newswire

PR Newswire - Aug 01, 2025

With merger in the books, Mallinckrodt and Endo rebrand as Keenova and spin off Par Health - Fierce Pharma

Fierce Pharma - Nov 11, 2025

Par Health Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

Yahoo Finance - Nov 10, 2025

Pryor Cashman Represents Wilmington Savings Fund Society, FSB, in $1.35B Secured Credit Facility for Mallinckrodt–Endo Merger - Pryor Cashman LLP

Pryor Cashman LLP - Aug 04, 2025

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - Morningstar

Morningstar - Mar 23, 2026

Par Health Q4 Spin-Off Lined Up As Mallinckrodt, Endo Conclude $6.7bn Merger - Citeline News & Insights

Citeline News & Insights - Aug 27, 2025

Endocyclic’s ENDO-205 awarded NIH grant for endometriosis - BioWorld News

BioWorld News - Sep 17, 2025

Endo Launches First and Only Generic Version of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in the United States - PR Newswire

PR Newswire - Oct 20, 2025

Endometrics Wins First Prize in NIH RADx Tech ACT ENDO Challenge - Yahoo Finance

Yahoo Finance - Mar 17, 2026

Aviva Biopharm Inc. Unveils Groundbreaking Pre-Clinical Data on d3-T, a First-in-Class Testosterone Therapy for Women at ENDO 2025 - Business Wire

Business Wire - Jul 14, 2025

Mallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc. - PR Newswire

PR Newswire - Jul 17, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment